v3.25.2
NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revisions of Previously Issued Audited Financial Statements (Details) - USD ($)
 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2023
Consolidated Balance Sheet      
Accounts receivable $ 589,074 $ 897,491  
Provision for credit losses 470,000 535,000 $ 157,012
Total current assets 9,816,279 8,143,793  
Total assets 9,816,279 8,334,750  
Accrued commissions and other 190,295 204,428  
Total Current Liabilities 4,652,568 3,658,393  
Accumulated Deficit (7,745,259) (8,245,943)  
Total Shareholders' Equity 5,163,711 4,663,027 $ 5,358,817
Total Liabilities and Shareholders' Equity 9,816,279 8,334,750  
Consolidated Statement of Operations      
Net sales (23,563,554) (19,517,673)  
Cost of goods sold 16,732,149 13,919,660  
Gross Profit 6,831,405 5,598,013  
Selling, General and Administrative expense 6,004,507 5,735,584  
Operating Loss 402,049 (564,805)  
Loss before income taxes 139,684 (695,790)  
Net Loss 500,684 (695,790)  
Consolidated Statement of Cash Flows (Operating Activities)      
Net Loss 500,684 (695,790)  
Allowance for credit losses (65,000) 377,988  
(Increase) Decrease in accounts receivable and amount due from factor (1,090,710) 186,806  
(Decrease) Increase in accounts payable and accrued expenses $ (192,016) 1,472,394  
As Reported      
Consolidated Balance Sheet      
Accounts receivable   1,101,991  
Provision for credit losses   325,000  
Total current assets   8,353,793  
Total assets   8,544,750  
Accrued commissions and other   114,428  
Total Current Liabilities   3,568,393  
Accumulated Deficit   (7,945,943)  
Total Shareholders' Equity   4,963,027  
Total Liabilities and Shareholders' Equity   8,544,750  
Consolidated Statement of Operations      
Net sales   (19,902,673)  
Cost of goods sold   14,094,660  
Gross Profit   5,808,013  
Selling, General and Administrative expense   5,645,584  
Operating Loss   (264,805)  
Loss before income taxes   (395,790)  
Net Loss   (395,790)  
Consolidated Statement of Cash Flows (Operating Activities)      
Net Loss   (395,790)  
(Increase) Decrease in accounts receivable and amount due from factor   354,794  
(Decrease) Increase in accounts payable and accrued expenses   1,382,394  
Adjustments      
Consolidated Balance Sheet      
Accounts receivable   (210,000)  
Provision for credit losses   210,000  
Total current assets   (210,000)  
Total assets   (210,000)  
Accrued commissions and other   90,000  
Total Current Liabilities   90,000  
Accumulated Deficit   (300,000)  
Total Shareholders' Equity   (300,000)  
Total Liabilities and Shareholders' Equity   (210,000)  
Consolidated Statement of Operations      
Net sales   385,000  
Cost of goods sold   (175,000)  
Gross Profit   (210,000)  
Selling, General and Administrative expense   90,000  
Operating Loss   (300,000)  
Loss before income taxes   (300,000)  
Net Loss   (300,000)  
Consolidated Statement of Cash Flows (Operating Activities)      
Net Loss   (300,000)  
Allowance for credit losses   377,988  
(Increase) Decrease in accounts receivable and amount due from factor   (167,988)  
(Decrease) Increase in accounts payable and accrued expenses   90,000  
As Revised      
Consolidated Balance Sheet      
Accounts receivable   891,991  
Provision for credit losses   535,000  
Total current assets   8,143,793  
Total assets   8,334,750  
Accrued commissions and other   204,428  
Total Current Liabilities   3,658,393  
Accumulated Deficit   (8,245,943)  
Total Shareholders' Equity   4,663,027  
Total Liabilities and Shareholders' Equity   8,334,750  
Consolidated Statement of Operations      
Net sales   (19,517,673)  
Cost of goods sold   13,919,660  
Gross Profit   5,598,013  
Selling, General and Administrative expense   5,735,584  
Operating Loss   (564,805)  
Loss before income taxes   (695,790)  
Net Loss   (695,790)  
Consolidated Statement of Cash Flows (Operating Activities)      
Net Loss   (695,000)  
Allowance for credit losses   377,988  
(Increase) Decrease in accounts receivable and amount due from factor   186,806  
(Decrease) Increase in accounts payable and accrued expenses   $ 1,472,394